Literature DB >> 25848506

Molecular diversity of Mycobacterium tuberculosis strains indifferent provinces of Iran.

Mohadese Mozafari1, Parissa Farnia1, Mona Afraei1, Zahra Derakhshani-Nezhad1, Mohammad Reza Masjedi1, Ali Akbar Velayati1.   

Abstract

BACKGROUND AND OBJECTIVES: Molecular epidemiology tools are widely used in determining epidemiology of tuberculosis. Spoligotyping is a molecular epidemiology method that is used for characterization and typing of Mycobacterium tuberculosis complex strains. The method is based on polymorphism of the chromosomal DR locus consisting of identical 36-bp DRs alternating with 35-41 unique spacers. The objective of this study was to investigate the prevalence of M. tuberculosis spoligotypes in different provinces of Iran.
MATERIALS AND METHODS: M. tuberculosis strains were isolated from TB patients of Mycobacteriology Research center (MRC). DNA was extracted from patient's clinical samples. PCR was performed by using of specific primers for DR region. The amplified DNA was hybridized to the spoligotyping Membrane. Hybridized DNA was detected with ECL detection kit and by exposing ECL Hyperfilm to the membrane. The obtained result was entered to a binary format and was analyzed using SpolDB4 database.
RESULTS: Spoligotyping resulted in 136 different patterns. Out of 1242 M. tuberculosis strains, 1165 strains (93.8%) were classified into 59 clusters and the remaining strains (6.2 %) were singleton.
CONCLUSIONS: The results of present study showed that strains of CAS family were more prevalent than other strains in Iran. Other prevalent families were Haarlem, T and Beijing, respectively.

Entities:  

Keywords:  Molecular epidemiology; Spoligotyping; Tuberculosis

Year:  2013        PMID: 25848506      PMCID: PMC4385162     

Source DB:  PubMed          Journal:  Iran J Microbiol        ISSN: 2008-3289


INTRODUCTION

Tuberculosis (TB) is one of the most urgent health problems in the Middle Eastern countries. Iran, with around 70 million inhabitants, shares geographical borders with four countries with high TB incidence rate, i.e. Pakistan, Afghanistan, Turkmenistan and Iraq. According to the World Health Organization (WHO), the estimated incidence rate of tuberculosis within the country is 21 per 100,000 populations (1). Therefore control and prevention of TB in Iran is the main health concern of national TB program. Genotyping of M. tuberculosis strains is important for TB control program, because it allows the detection of outbreaks, the tracing of transmission, to monitor species diversity and to identify secondary infections (2, 3). Large scale genotyping of M. tuberculosis using IS6110 restriction fragment length polymorphism is labor-intensive, time consuming and the results are sometimes difficult to compare among laboratories (2, 4). Based on this knowledge we used an easier and more rapid method in order to differentiate M. tuberculosis strains. Spoligotyping is a PCR based method that permits genotyping of M. tuberculosis complex in a rapid, reliable and cost effective way. The method is based on hybridization of amplified DNA with spacer oligonucleotides. The DR region contains multiple short 36-bp direct repeats (DRs) interspersed with unique spacers, which are 35-41 bp in length (5). The DRs are extremely well conserved among M. tuberculosis complex strains, making spoligotyping a specific method for the genotyping of M. tuberculosis complex members (5). A total of 9 potential super families or clades of M. tuberculosis complex have been identified by spoligotyping method (M. africanum, Beijing, M. bovis, EAI, CAS, T group of families, Haarlem, X and LAM family) (6). In this study, we performed spoligotyping on M. tuberculosis complex strains collected from all over the country, which were isolated between 2010 and 2011, in order to provide preliminary insight into the population structure of M. tuberculosis circulating in the country as well as the distribution of MTB family strains in provinces of Iran.

MATERIALS AND METHODS

M. tuberculosis strains and DNA isolation

A total of 1242 M. tuberculosis strains collected from 24 different provinces of Iran (2010-2011). Clinical specimens were transferred to Mycobacteriology Research Center (MRC). Mycobacterial genomic DNA was extracted from patient’s samples using QIAamp® DNA mini kit (QIAGEN).

Spoligotyping

Spoligotyping was performed as previously described by Kamerbeek et al, (5). The DR region was amplified by PCR using primers DRa (5’-biotin -CCG AGA GGG GAC GGA AAC- 3’) and DRb (5’- GGT TTT GGG TCT GAC GAC-3’), 20-50ng of DNA and 0.5 U of Taq DNA polymerase (Cinnagen, Tehran, Iran). The PCR condition was: 35 cycles of 1 min at 95°C, 1 min at 55°C and 30 sec at 72°C. The first denaturation and final extension steps were held for 10 min. The amplified DNA was hybridized to 43 immobilized oligonucleotides derived from the spacer sequences of MTB H37Rv and M. bovis BCG P3 by reverse line blotting. Hybridized DNA was detected by enhanced chemiluminesence (ECL, Amersham, UK) and by exposing ECL-Hyper film (Amersham) to the membrane for 10 min. Obtained results were entered in a binary format as excel spreadsheets (Microsoft) and compared with published data (7-10). The strains with spoligotype similar to any pattern of M. tuberculosis strain already found in the database were automatically labeled with an already defined ‘shared type’number. Any spoligotype exhibiting a profile not yet found anywhere in the SpolDB4 database was termed as orphan (not seen) strain.

RESULTS

Spoligotyping produced a total of 136 patterns for the 1242 strains. Fifty-nine patterns classified into clusters in the present study (the data are summarized in Table 1 and detailed in Table 2). Fifty nine clusters contained 1165 isolates, which amounted 93.8% of clustering rate (1165/1242).The remainers (n = 77) corresponded to singleton which were not classified into any clusters (Table 3).
Table 1

Spoligotypes of the 5 most prevalent clades with a Shared Type number in SITVIT databade.

M.tb StrainShared TypeNo. of isolates (%)Spoligo pattern (binary)Spoligo pattern (octal)
H4127255 (20.5%)nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnonoooonnnnnnn777777777720771
CAS1_DELHI26238 (19.1%)nnnoooonnnnnnnnnnnnnnnoooooooooooonnnnnnnnn703777740003771
T153140 (11.2%)nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnoooonnnnnnn777777777760771
CAS1_DELHI25126 (10.1%)nnnoooonnnnnnnnnnnnnnnoooooooooooonnoonnnnn703777740003171
Beijing1101 (8.1%)oooooooooooooooooooooooooooooooooonnnnnnnnn000000000003771
Table 2

Spoligotype of other Clustered strains.

MTB StrainsShared TypeNo. of isolatesSpoligo pattern (binary)Spoligo pattern (octal)
CAS2224nnnoooonnnnnnnnnnnnoooooooooooooooonnnnnnnn703777400001771
CAS35720nnnoooonnnnnnnnnnnnnnnoooooooooooooonnnnnnn703777740000771
MANU 25419nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnoonnnnnnnnn777777777763771
H465617nonnnnnnnnnnnnnnnnonnnnnnnnnooonoooonnnnnnn577777377420771
H329415nonnnnnnnnnnnnnnnnnnnnnnnnnnnnonoooonnnnnnn577777777720771
CAS1_KILI2114nnnoooonnonnnnnnnnnoooooooooooooooonnnnnnnn703377400001771
H426212nnnnnnnoonnnnnnnnnnnnnnnnnnnooonoooonnnnnnn774777777420771
Not seen10noonnnnnnnnnnnnnnnnnnnnnnnnnooonoooonnnnnnn477777777420771
H47778nnnnnnnnnnnnnnnnnnnnnnnnnnnnooonoooonnnnnnn777777777420771
Not seen8nnnoooonnnnnnooooooooooonnnnnnnnoooonnnnnnn703740007760771
H319087nnnnnnnnnnnnnnnnnnnnnnnnnnooooonoooonnnnnnn777777776020771
T12847oooonnnnnnnoonnnnnnnnnnnnnnnnnnnoooonnnnnnn37637777760771
CAS1426nnnoooonnnnnnnnnnnnnnooooooooooooonnnnnnnnn703777700003771
CAS4856nnnoooonnnnnnnnnnnnooooooooooooooonnnnnnnnn703777400003771
CAS1_DELHI3816nnnoooonnnnnnnnnnnnnnnoooooooooooonnooonnnn703777740003071
LAM9426nnnnnnnnnnnnnnnnnnnnoooonnnnnnnnoooonnnnnnn777777607760771
T12726oooonnnnnnnnnnnnnnnnnnnnnnnnnnnnoooonnnnnnn37777777760771
T16286nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnoooonnnnnoo777777777760760
U6026nnnnnnnnnnnnnnnnnnnnnnnnoooooooooooonnnnnnn777777770000771
BOVIS5955nnonnnnnonnnnnnnnnnnnnnnnnnnnnnnnnnnnnooooo676777777777600
LAM3 and S/convergent45oooooooooooooooooooooooonnnnnnnnoooonnnnnnn000000007760771
U11885nnnnnnnnnnnnnnnnnnnnnnnnnnnooooooonnnnnnnnn777777777003771
Not seen5nnnnonnnnnnnnnnnnnnnnnnnnnnnnnnnoonnnnnnnnn757777777763771
Not seen5nnnnnnnnnnnnnnnnnnnnnnnnnnnooooooooonnnnnnn777777777000771
BOVIS4824nnonnnnnonnnnnnonnnnnnnnnnnnnnnnnnnnnnooooo676773777777600
CAS4864nnnoooonnnnnnnnnnnnnnnooooooooooooooonnnnnn703777740000371
T111664nnnnnnnnnonnnnnnnnnnnnnnnnnnnnnnoooonnnnnnn777377777760771
Not seen4nonoonnnnnnnnnnnnnnnnnnnnnnnooonoooonnnnnnn517777777420771
CAS8643nnnoooonnnnnnooooooooooooooooooooooonnnnnoo703740000000760
CAS10893noooooonnnnnnnnnnnnnnnoooooooooooonnnnnnnnn403777740003771
CAS10933nnnoooonnnnnnnnnnnnnoooooooooooooonnnnnnnnn703777600003771
CAS12643nnnoooonnnnnnnnnnnnnnnooooooooooooooooooooo703777740000000
MANU 216343nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnonoonnnnnnnnn777777777723771
T15203nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnoooononnnnn777777777760571
T111443nnnnnnnnnnnnnnnnnnnnooooooonnnnnoooonnnnnnn777777600760771
U(CAS_ANCESTOR?)273nnnoooonnnnnnnnnnnnnnnoonnnnnnnnnoooonnnnnn703777747770371
Not seen3nnnnnnnnnnnoooonoooooooooooooooooooonnooonn777604000000611
CAS5992nnnoooonnnnnnnnnnnnooooooooooooooooonnnnnnn703777400000771
CAS1_DELHI4272nnnoooonnnnnooonnnnnnnoooooooooooonnnnnnnnn703707740003771
CAS1_DELHI4282nnnoooonnnnnnnnnnnnnnnoooooooooooonnonnnnnn703777740003371
CAS1_DELHI10922nnnoooononnnnnnnnnnnnnoooooooooooonnnnnnnnn702777740003771
CAS1_DELHI13142nnnoooonnonnnnnnnnnnnnoooooooooooonnoonnnnn703377740003171
H43612nonnnnnnnnnnonnnnnnnnnnnnnnnooonoooonnnnnnn577737777420771
H45972nonnnonnnnnnnnnnnnnnnnnnnnnnooonoooonnnnnnn567777777420771
H47642nnnnnnnnnnnnnonnnnnnnnnnnnnnnnonoooonnnnnnn777757777720771
H415682nnnnnnnoonnnnnnnnnonnnnnnnnnooonoooonnnnnnn774777377420771
MANU 216902nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnoononnnnnnn777777777762771
T116262nnnnnnnnnnnnnnnnnnnnnnnnnnonnnnnoooonnnnnnn777777776760771
T3372nnnnnnnnnnnnonnnnnnnnnnnnnnnnnnnoooonnnnnnn777737777760771
U3742nnnnnnnnnnnnnnnnnnnnnnononooooooooooooooooo777777752000000
Not seen2nnnnnnnnnnnnonnnnnnnnnnnnnnooooooooonnnnnnn777604000000611
Not seen2nonnoooooonnnnnnnnnnnnnnnnnnooonoooonnnnnno517777777420771
Not seen2nonnoooooonnnnnnnnnnnnnnnnnnooonoooonnnnnoo517777777420771
Not seen2nnnnnnnnnnnnonnnnnnnnnnnnnnooooooooonnnnnnn777737777000771
Table 3

Spoligotype of non-clustered strains.

MTB StrainsShared TypeNo. of isolatesSpoligo pattern (binary)Spoligo pattern (octal)
BOVIS6941nnonnnnnonnnnooonnnnnnnnnnnnnnnnnnnnnnooooo676743777777600
CAS14221nnnoooonnnnnnnnnnnoooooooooooooooooonnnnnnn703777000000771
CAS16161ooooooonnnnnnnnnnnnnnnoooooooooooonnnnnnnnn003777740003771
CAS1_DELHI2891nnnoooonnnnnnnnnnnnnnnoooooooooooonnnonnnnn703777740003571
CAS1_DELHI7541nonoooonnnnnnnnnnnnnnnoooooooooooonnnnnnnnn503777740003771
CAS22881nnnooooooonnnnnnnnnnnnoooooooooooonnnnnnnnn700377740003771
EAI52361nnnnnnnnnnnnnnnnnnnnnnnnnnnnoooononnnnnnnnn777777777413771
EAI5orEAI381noooooooooooonnnnnnnnnnnnnnnoooononnnnnnnnn400037777413771
EAI8_MDG1091noonnnnnnnnnnnnnnnonnnnnnnnnoooononnnnnnnnn477777377413771
H3501nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnonoooonnnnnnn777777777720771
H35111nnnnnnnnnnnnnnnnnnnnnoooooooooonoooonnnnnnn777777700020771
H3-T3361nnnnnnnnnnnnonnnnnnnnnnnnnnnnnonoooonnnnnnn777737777720771
H4351nnnnnnnnnnnnonnnnnnnnnnnnnnnooonoooonnnnnnn777737777420771
LAM11-ZWE591nnnnnnnnnnnnnnnnnnnnoooonnoooonnoooonnnnnnn777777606060771
LAM6641nnnnnnnnnnnnnnnnnnnnoooonnnnonnnoooonnnnnnn777777607560771
LAM94921nnnnnnonnnnnnnnnnnnnoooonnnnnnnnoooonnnnnnn773777607760771
LAM97701nnnnnnnnnnnonnnnnnnnoooonnnnnnnnoooonnnnnnn777677607760771
MANU 211921nnnnnnnnnnnnnnnnnnnnonnnnnnnnnnnoonnnnnnnnn777777677763771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_rus22801nnnnnnoooooooooooonnnnnnnnnnnnnnoooonnnnnnn770000777760771
T1_RUS28991nnonnnoooooooooooonnnnnnnnnnnnnnoooonnnnnnn670000777760771
T1_RUS211731nnnnnnoooooooooooonnnnnnnnnnnnnnoooonnnonnn770000777760731
T2521nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnoooonnnonnn777777777760731
T316551nnnnnnnnnnnnonoonnnnnnnnnnnnnnnnoooonnnnnnn777723777760771
U1721nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnooooonnnnnnn777777777740771
X17081nnnonnnnnnnnnnnnnonnnnnnnnnnnnnnoooonnnnnnn737776777760771
X23021nnnnnnnnnnnnnonnnonnnnnnnnnnnnnnoooonnnnnnn777756777760771
Not seen1nononnnnnooooonnnnnnnnnnnnnnnnnnoooonnnnnnn537017777760771
Not seen1nonnnnnnooooonnnnnnnnnnnnnnnooonoooonnnnnnn576037777420771
Not seen1nnnoooonnnnnnnnnnnnnnnnnnnnonnnnoonnnnnnnnn703777777363771
Not seen1nnnnnnnnnnnnnnnnnnnnnnnnnnnnoooooooooooonnn777777777400031
Not seen1ooooooooooonnnnnnnnnnnnnnnnnooonoooonnnnnnn000177777420771
Not seen1nnnnnnnnnonnnnnnnnnnnnnnnnnnnnnnoonnnnnnnnn777377777763771
Not seen1nnnoooonnnnnnnnnnnnnnnnnnnooononoonnnnnnnnn703777776123771
Not seen1nnnnnnnnnonononnnnnnnnnnnnnnnoonoooonnnnnnn777257777620771
Not seen1nnnnnoonnoonnnnoooooonnnnnnnnnnnooooonnnnnn763170077760371
Not seen1nnnoooonnnnnnnnnnnoooooooooooooooooonnnnnnn703777000000771
Not seen1nnnoooonnonnnnooooooooooooooooooooooonnnnnn703360000000371
Not seen1nonnnnnnnonnnonnnnnnnnnnnnnnooonoooononnnnn577357777420571
Not seen1nnnnnnnnnnnnnoonnnnnnnnnnoonnnnnnnnnnnonnon777747774777661
Not seen1nnnnnnnnnoooononnnnnnnnnnnooooononnnnnnnnnn777027776027771
Not seen1nnnnnnnnnnnoonnnnnnnoooonnnnnnnnoooonnnnnnn777637607760771
Not seen1nnnnnnnnnnnnnnnnnnonnnnnnnnnnnooooonnnnnnnn777777377701771
Not seen1nnnoooonnnnnnnnnnnnnnoooooooooooooonnnnnnnn703777700001771
Not seen1nnnoooonnonnnnnnnnnnnooooooooooooooonnnnnnn703377700000771
Not seen1nnnoooonnnnnnooooooooooooooooooooooonnnnnnn703740000000771
Not seen1nnnnonnnnonnonnnnnnnnnnnnnnnooonoooonnnnnnn757337777420771
Not seen1nnnoooonnnnnnnnnnooonnoooooooooooonnnnnnnnn703776140003771
Not seen1nnnoooonnnnnnooonnnnnnoooooooooooooonnnnnon703743740000761
Not seen1nnnnonnnoonnonnnnnnnnnnnnnnnooonoooonnnnnnn756337777420771
Not seen1nnnnnnnnnonnnonnnonnnonnnnnnnnnnoooonoonnnn777356737760471
Not seen1nnnnnnnnnnnnnnnnnnnnnnnnnnnnooonoonnnnnnnnn777777777423771
Not seen1nnnooooononoooonnnonnnnnnnnnnnnnoooonnnnnnn701207377760771
Not seen1nnnnnnonnonnnoonnnnnnnnnnnonnnnnooonononnnn773347776761271
Not seen1nnnnnnnnnnnnnoooooooooooonnnnnnnoooonnnnnnn777740003760771
Not seen1nonnnnnooonnnnnnnnnnnnnoonnnooonoooonnnnnnn574377763420771
Not seen1oooonnnnnnnoonnnnnnnnnnnnnnnnnnnoooonnnonnn037637777760731
Not seen1oonoooonnnnnnnnnnnnnnnoooooooooooonnnnnnnnn103777740003771
Not seen1noonnnnnnnnnnnnnnnnnnnnnnnnooooonoooooonnnn477777777010071
Not seen1nonnnnnnnnnnnnnnnnnnnnnnnnnnooonoooonnnnnoo577777777420760
Not seen1nnnnnnnnoonnooonnnnnnnoooooooooooonnoonnnnn776307740003171
Among the 1242 typed isolates, 1165 (93.8%) were classified as shared international types (SITs) according to SITVIT database. The remaining 77 isolates generated 44 new spoligotypes (orphan- not seen) that had not been previously described in the database. Among the 59 clusters, we found 46 minor spoligotypes (including 2 to 9 isolates) and 13 major spoligotypes (> 10 isolates). Isolates ST127 (20.5%; Haarlem family), ST26 (19.1%; CAS family), ST53 (11.2%; T family), ST25 (10.1%; CAS family), and ST1(8.1%; Beijing family) represent almost 70% of the total number of isolates in this study. The spoligotyping analysis identified the strains in the familes of CAS (n = 471, 37.9%), Haarlem (n = 326, 26.2%), T (n = 195, 15.7%) and Beijing (n = 101, 8.1%). Other spoligotypes belongs to Manu (n = 25, 2%), LAM (n = 13, 1%), U (n = 17, 1.3%), EAI (n = 3, 0.2%), Bovis (n = 10, 0.8%), X (n = 2, 0.16%) and the remianing (n = 77, 6.1%) were orphan. High spoligotype diversity was documented for CAS, Haarlem and T lineages. Although LAM family was not frequent in this study, a high diversity was also evidenced for this lineage (6 sublineages). Furthermore, 6 M. bovis strains and 4 M. bovis BCG strains were found in this study which classified into 3 clusters.

Geographical distribution of Spoligotypes in Iran

The geographical distribution of M. tuberculosis spoligotypes is shown in Table 4. The most prevalent families were CAS (37.9%) followed by Haarlem (26.2%), T (15.7%), Beijing (8.1%). CAS family strains were predominant in 15 provinces (Khouzestan, Esfahan, Fars, Qazvin, Gilan, Golestan, Hamedan, Hormozgan, Boushehr, Kerman, Kermanshah, Markazi, Tehran, Yazd, Lorestan); strains of Haarlem family were predominant in Qom, Semnan, Kordestan and eastern border provinces, i.e. Khorasan and Sistan -Balouchestan.
Table 4

geographical distribution of Mycobacterium tuberculosis spoligotypes in Iran.

KhouzestanEast and West Azarbaijian/ArdebilEsfahanFarsQazvinGilanGolestanHamedanHormozgan /BoushehrKermanKermanshahKhorasanKordestanMarkaziMazandaranQomSemnanTehranYazdSistan- BalouchestanLorestanTotal
BEIJING5765615112311013531018.1%
LAM7211112151.2%
BOVIS12124100.8%
CAS6716171661823719109344941871076591547137.9%
EAI2130.2%
HAARLEM710214213858824293620885265732626.2%
MANU211113142252%
T1329121283424193138547416219515.7%
U61262171.3%
X1120.16%
UNKNOWN93352434132317776.1%
TOTAL11965424010394721382416117161526612132412165241242
Strains of T family were predominant in Mazan daran, East and West Azerbaijan and Ardebil provinces (North western provinces). Distribution of Beijing strains was higher inTehran, Khorasan and Qom provinces.

DISCUSSION

This study aimed to assess the genetic diversity of M. tuberculosis strains collected from 24 provinces of Iran using the spoligotyping method. Although these strains were not representative of all strains presented in Iran, they provided an insight into the population structure of M. tuberculosis spoligotypes in the country. Previously, the M. tuberculosis isolates were classified into 3 distinct genetic groups by Sreevatsan et al (11): Group I or ancient MTB genotype (CAS, Beijing, EAI) and Group II and III (Haarlem, T, LAM, U, X) which called Modern MTB genotypes. In a similar study, M. tuberculosis isolates belonged to genetic groups II and III failed to hybridize with spacers 33 to 36, suggesting that these spacers and DRs have become deleted from the genome of all these groups (12). In the present study, the prevalence of ancient TB was 47.9% and the prevalence of modern TB was 45.3%. Another study by Merza et al, reported that the prevalence of ancient and modern TB in Iran was almost equal, whereas in Pakistan and Afghanistan, the majority of strains belonged to ancient MTB genotype. In contrast, modern MTB strains were prevalent in Turkey. Therefore they considered Iran as the connecting geographical location between ancient and modern TB (13). The CAS family which was the most prevalent lineage in our results is essentially localized in Central and Middle Eastern Asia (14). It belongs to ancient TB and its prevalence is steadily decreasing from south Asia to Western Asia. This genotype might be an ancestor of the Beijing lineage since it clusters close to Beijing when analyzed by a combination of MIRU-VNTR and Spoligotyping (14). The Haarlem family was first isolated from a patient living in Haarlem, the Netherlands (7). Today its widespread distribution in different geographical regions of the world such as Asia, Europe and Africa, has been documented (15, 16). A study conducted in Iran revealed that this family accounts for more than half of all clustered strains among Iranian MDR-TB (Multi-drug resistant tuberculosis) patients (16). In our study, Haarlem family was prevalent in 5 provinces (Khorasan, Kordestan, Sistan-Balouchestan, Qom and semnan) and the prevalence of T family was higher in north-western provinces (East and West Azarbaijan, Ardebil and Mazandaran). The Beijing genotype was originally described by Van Soolingen et al (21). This family has spread globally during recent years with the highest prevalence found in Asia and the territory of the former Soviet Union (17-19). The frequency of Beijing genotype was higher in Tehran, Qom and Khorasan provinces due to high migration rate from other provinces or countries with high burden of Beijing genotype to these areas. In this study the prevalence of Beijing genotype was 8.1%; in previous studies the prevalence of this genotype in Tehran, Mashhad and Shiraz was 5.5%, 7.1% and 10%s respectively, (6, 17, 20). Although our results demonstrated that the most prevalent family in Iran is CAS Lineage, this family is not necessarily prevalent in each provinces of Iran. The high frequency of Beijing strains in provinces with high migration rate should be considered, due to association of this family with drug resistance.
  20 in total

Review 1.  The evolution of mycobacterial pathogenicity: clues from comparative genomics.

Authors:  R Brosch; A S Pym; S V Gordon; S T Cole
Journal:  Trends Microbiol       Date:  2001-09       Impact factor: 17.079

2.  Evolutionary relationships among strains of Mycobacterium tuberculosis with few copies of IS6110.

Authors:  Jeremy W Dale; Hasan Al-Ghusein; Salim Al-Hashmi; Philip Butcher; Anne L Dickens; Francis Drobniewski; Ken J Forbes; Stephen H Gillespie; Dianie Lamprecht; Timothy D McHugh; Richard Pitman; Nalin Rastogi; Andrew T Smith; Christophe Sola; Hasan Yesilkaya
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

3.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

4.  Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility.

Authors:  K Kremer; D van Soolingen; R Frothingham; W H Haas; P W Hermans; C Martín; P Palittapongarnpim; B B Plikaytis; L W Riley; M A Yakrus; J M Musser; J D van Embden
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

5.  The most predominant spoligopatterns of Mycobacterium tuberculosis isolates among Iranian, Afghan-immigrant, Pakistani and Turkish tuberculosis patients: a comparative analysis.

Authors:  Muayad A Merza; Parissa Farnia; Ahmad M Salih; Mohammad Reza Masjedi; Ali Akbar Velayati
Journal:  Chemotherapy       Date:  2010-06-16       Impact factor: 2.544

6.  Global distribution of Mycobacterium tuberculosis spoligotypes.

Authors:  Ingrid Filliol; Jeffrey R Driscoll; Dick Van Soolingen; Barry N Kreiswirth; Kristin Kremer; Georges Valétudie; Dang Duc Anh; Rachael Barlow; Dilip Banerjee; Pablo J Bifani; Karine Brudey; Angel Cataldi; Robert C Cooksey; Debby V Cousins; Jeremy W Dale; Odir A Dellagostin; Francis Drobniewski; Guido Engelmann; Séverine Ferdinand; Deborah Gascoyne-Binzi; Max Gordon; M Cristina Gutierrez; Walter H Haas; Herre Heersma; Gunilla Källenius; Eric Kassa-Kelembho; Tuija Koivula; Ho Minh Ly; Athanasios Makristathis; Caterina Mammina; Gerald Martin; Peter Moström; Igor Mokrousov; Valérie Narbonne; Olga Narvskaya; Antonino Nastasi; Sara Ngo Niobe-Eyangoh; Jean W Pape; Voahangy Rasolofo-Razanamparany; Malin Ridell; M Lucia Rossetti; Fritz Stauffer; Philip N Suffys; Howard Takiff; Jeanne Texier-Maugein; Véronique Vincent; Jacobus H De Waard; Christophe Sola; Nalin Rastogi
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

7.  Molecular diversity of Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in Mozambique.

Authors:  Sofia O Viegas; Adelina Machado; Ramona Groenheit; Solomon Ghebremichael; Alexandra Pennhag; Paula S Gudo; Zaina Cuna; Paolo Miotto; Véronique Hill; Tatiana Marrufo; Daniela M Cirillo; Nalin Rastogi; Gunilla Källenius; Tuija Koivula
Journal:  BMC Microbiol       Date:  2010-07-21       Impact factor: 3.605

Review 8.  Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements.

Authors:  D Van Soolingen
Journal:  J Intern Med       Date:  2001-01       Impact factor: 8.989

9.  Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia.

Authors:  D van Soolingen; L Qian; P E de Haas; J T Douglas; H Traore; F Portaels; H Z Qing; D Enkhsaikan; P Nymadawa; J D van Embden
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

10.  Spoligotype database of Mycobacterium tuberculosis: biogeographic distribution of shared types and epidemiologic and phylogenetic perspectives.

Authors:  C Sola; I Filliol; M C Gutierrez; I Mokrousov; V Vincent; N Rastogi
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

View more
  7 in total

1.  A pilot study on the genetic diversity of Mycobacterium tuberculosis complex strains from tuberculosis patients in the Littoral region of Cameroon.

Authors:  Benjamin D Thumamo Pokam; D Yeboah-Manu; P M Teyim; P W Guemdjom; B Wabo; A B D Fankep; R E Okonu; Anne E Asuquo
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-09-01

2.  Drug Resistance Pattern of Mycobacterium tuberculosis Isolates From Patients Referred to TB Reference Laboratory in Ahvaz.

Authors:  Fereshteh Badie; Maniya Arshadi; Maryam Mohsenpoor; Soodabeh S Gharibvand
Journal:  Osong Public Health Res Perspect       Date:  2015-11-03

Review 3.  Molecular typing methods used in studies of Mycobacterium tuberculosis in Iran: a systematic review.

Authors:  Hassan Ravansalar; Keyvan Tadayon; Kiarash Ghazvini
Journal:  Iran J Microbiol       Date:  2016-10

4.  Control of zoonotic cutaneous leishmaniasis vector, Phlebotomus papatasi, using attractive toxic sugar baits (ATSB).

Authors:  Abedin Saghafipour; Hassan Vatandoost; Ali Reza Zahraei-Ramazani; Mohammad Reza Yaghoobi-Ershadi; Yavar Rassi; Moharram Karami Jooshin; Mohammad Reza Shirzadi; Amir Ahmad Akhavan
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

5.  Smear positive tuberculosis and genetic diversity of M. tuberculosis isolates in individuals visiting health facilities in South Gondar Zone, northwest Ethiopia.

Authors:  Amir Alelign; Beyene Petros; Gobena Ameni
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

Review 6.  Role of Immigration in Tuberculosis Transmission to Iran: A Systematic Review.

Authors:  Amir Mohammadzadeh; Jalil Rashedi; Behroz Mahdavi Poor; Hossein Samadi Kafil; Mahya Pourostadi; Abdolhassan Kazemi; Mohammad Asgharzadeh
Journal:  Int J Prev Med       Date:  2020-12-30

7.  Challenge in direct Spoligotyping of Mycobacterium tuberculosis: a problematic issue in the region with high prevalence of polyclonal infections.

Authors:  Mansour Kargarpour Kamakoli; Sharareh Khanipour; Shima Hadifar; Hasan Ghajavand; Ghazaleh Farmanfarmaei; Abolfazl Fateh; Seyed Davar Siadat; Farzam Vaziri
Journal:  BMC Res Notes       Date:  2018-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.